Tag: anemia drug

FDA, Regulations

GSK secures FDA approval of anemia drug, but with limitations

February 2, 2023

Via: Biopharma Dive

Jesduvroq belongs to a new class of oral treatments that GSK, along with rivals FibroGen and Akebia Therapeutics, saw as more convenient alternatives to the injectable medicines that are currently standard for treating kidney disease-related anemia. But in August 2021 […]